The role of platinum dose intensity in the management of ovarian cancer.
作者信息
Markman M
出版信息
J Cancer Res Clin Oncol. 1993;119(9):511-2. doi: 10.1007/BF01686459.
Abstract
摘要
相似文献
1
The role of platinum dose intensity in the management of ovarian cancer.铂剂量强度在卵巢癌治疗中的作用。
J Cancer Res Clin Oncol. 1993;119(9):511-2. doi: 10.1007/BF01686459.
2
Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer.新诊断的II期、III期或IV期上皮性卵巢癌术后患者一线化疗的系统评价
Gynecol Oncol. 2002 Apr;85(1):71-80. doi: 10.1006/gyno.2001.6552.
3
Different infusion durations for preventing platinum-induced hearing loss in children with cancer.预防癌症患儿铂类药物所致听力损失的不同输注持续时间
Cochrane Database Syst Rev. 2016 Aug 8(8):CD010885. doi: 10.1002/14651858.CD010885.pub3.
4
A systematic overview of chemotherapy effects in ovarian cancer.卵巢癌化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):340-60. doi: 10.1080/02841860151116420.
5
Different infusion durations for preventing platinum-induced hearing loss in children with cancer.预防癌症患儿铂类药物所致听力损失的不同输注持续时间
Cochrane Database Syst Rev. 2018 Jul 5;7(7):CD010885. doi: 10.1002/14651858.CD010885.pub4.
6
Optimal dosing with carboplatin.
Semin Oncol. 1989 Apr;16(2 Suppl 5):14-8.
7
Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer.基于卡铂的腹腔内化疗用于上皮性卵巢癌。
Gynecol Oncol. 2005 Apr;97(1):10-5. doi: 10.1016/j.ygyno.2004.12.005.
8
The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer.紫杉醇与新型铂类化合物在晚期卵巢癌治疗中的联合应用。
Int J Gynecol Cancer. 2001;11 Suppl 1:21-30. doi: 10.1046/j.1525-1438.2001.11(suppl.1)sup1021.x.
9
Platinum-containing regimens for metastatic breast cancer.转移性乳腺癌的含铂方案。
Cochrane Database Syst Rev. 2017 Jun 23;6(6):CD003374. doi: 10.1002/14651858.CD003374.pub4.
10
Carboplatin substitution for cisplatin in the treatment of ovarian carcinoma--a word of caution.
J Natl Cancer Inst. 1989 Oct 4;81(19):1438-9. doi: 10.1093/jnci/81.19.1438.
引用本文的文献
1
Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours.实体瘤患者中顺铂暴露、白细胞中DNA加合物形成与肿瘤反应之间的关系。
Br J Cancer. 1996 Jun;73(12):1569-75. doi: 10.1038/bjc.1996.296.
本文引用的文献
1
Novel, dose intensive, single-agent cisplatin in the first-line management of advanced stage ovarian cancer.新型、高剂量单药顺铂在晚期卵巢癌一线治疗中的应用。
Int J Gynecol Cancer. 1992 Nov;2(6):301-6. doi: 10.1046/j.1525-1438.1992.02060301.x.
2
High-dose cisplatin in hypertonic saline.高剂量顺铂溶于高渗盐水中。
Ann Intern Med. 1984 Jan;100(1):19-24. doi: 10.7326/0003-4819-100-1-19.
3
Dose intensity analysis of chemotherapy regimens in ovarian carcinoma.卵巢癌化疗方案的剂量强度分析
J Clin Oncol. 1987 May;5(5):756-67. doi: 10.1200/JCO.1987.5.5.756.
4
cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.顺二氯二氨合铂（II）在敏感和耐药的人卵巢癌细胞中的积累。
Cancer Res. 1988 Jan 1;48(1):68-73.
5
A randomized study of high-dose versus low-dose cis-platinum combined with cyclophosphamide in the treatment of advanced ovarian cancer. Hong Kong Ovarian Carcinoma Study Group.
Chemotherapy. 1989;35(3):221-7. doi: 10.1159/000238673.
6
Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer.卵巢癌的长期生存。来自荷兰卵巢癌联合研究小组的成熟数据。
Eur J Cancer. 1991;27(11):1367-72. doi: 10.1016/0277-5379(91)90011-2.
7
Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.晚期卵巢癌的化疗：随机临床试验综述。晚期卵巢癌试验协作组
BMJ. 1991 Oct 12;303(6807):884-93. doi: 10.1136/bmj.303.6807.884.
8
Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.卵巢癌患者中卡铂暴露与肿瘤反应及毒性之间的关系。
J Clin Oncol. 1992 Apr;10(4):520-8. doi: 10.1200/JCO.1992.10.4.520.
9
The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: "maintenance" therapy reconsidered.
Gynecol Oncol. 1992 Oct;47(1):7-13. doi: 10.1016/0090-8258(92)90067-s.
10
Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer.两种剂量顺铂联合环磷酰胺治疗上皮性卵巢癌的随机研究。
Lancet. 1992 Aug 8;340(8815):329-33. doi: 10.1016/0140-6736(92)91404-v.
Zotero 插件